AML - Onco'Zine

Home Tags AML

CD3xCD123 Bispecific Antibody APVO436 Shows Benefit in Relapsed AML and...

Editorial Team - August 18, 2021

$Patients with Relapsed/Refractory AML may Benefit from Treatment with Ficlatuzumab + Chemotherapy$

Patients with Relapsed/Refractory AML may Benefit from Treatment with Ficlatuzumab +...

Editorial Team - July 18, 2021

General Views during at the American Society of Hematology 61th Annual Meeting at the Orange County Convention Center. Photo Courtesy © 2019 ASH/Danny Morton.

ASH 2020: Preclinical Models Identify CD74 as Potential Target for the...

Peter Hofland, Ph.D - December 8, 2020

Speakers and attendees during Poster Session 1 at the American Society of Hematology 61th Annual Meeting at the Orange County Convention Center, Friday December 6, 2019. Photo Courtesy American Society of Hematology © 2019 ASH/Nick Agro

ASCO 2020: How Disparities and Inequities Affect Health

Danielle Garcia - December 4, 2020

AbbVie booth at the 2019 annual meeting of the American Society of Clinical Oncology (ASCO) held June 1 - 4, 2019 in Chicago, Ill.

U.S. FDA Approves Venetoclax for the Treatment of Acute Myeloid Leukemia

Editorial Team - October 16, 2020

A Compound Being Developed to Treat an Eye Disease may also...

Peter Hofland, Ph.D - January 2, 2019

Daiichi Sankyo Initiates Phase I Study to Evaluate the Combination Quizartinib...

Peter Hofland, Ph.D - December 20, 2018

Gilteritinib Available for Prescription in the United States for Adults with...

Peter Hofland, Ph.D - December 11, 2018

Glasdegib Approved in Newly-Diagnosed AML Patients for Whom Intensive Chemotherapy is...

Peter Hofland, Ph.D - November 24, 2018

FDA Grants Accelerated Approval for Venetoclax in Newly-Diagnosed Acute Myeloid Leukemia...

Peter Hofland, Ph.D - November 24, 2018

12 Page 1 of 2

LATEST NEWS

Soft-Tissue Sarcomas Changes the Biology of Immune Cells Surrounding Tumors to Promote Tumor Growth

Editorial Team - June 22, 2022

Activating the Immune Response Enables Liver Cancer Patient’s Immune System to Kill Cancerous Cells

Editorial Team - June 21, 2022

Statue of a Woman with Incurable Breast Cancer Unveiled in Front of the Norwegian...

Editorial Team - June 20, 2022

Preventive Care May Be Free, but Follow-Up Diagnostic Tests Can Bring Big Bills

Michelle Andrews - June 14, 2022

Pioneering Novel Targeted Treatments in Lung Cancer

Editorial Team - June 10, 2022

Press Releases | Cancer

Mediaplanet Partners With Hematology Industry to Improve the... June 30, 2022
Mediaplanet’s Blood Health campaign, found within USA TODAY and online, unites organizations, experts, blood disorder and cancer patients, and families to raise awareness and educate the public about...(PRWeb June 30, 2022)Read the full story at https://www.prweb.com/releases/mediaplanet_partners_with_hematology_industry_to_improve_the_conversation_around_blood_health/prweb18766758.htm
HALO Diagnostics, IncellDx Partner to Advance Novel Testing, Improve... June 29, 2022
The precision diagnostics leader and molecular diagnostics company are joining forces to develop new, innovative testing for urogenital cancers that will improve the standard of care.(PRWeb June 29, 2022)Read the full story at https://www.prweb.com/releases/2022/6/prweb18764263.htm
P-Cure to support Hadassah Medical Organization in being the first to... June 28, 2022
P-Cure Ltd., the provider of the most compact 360° gantry-less adaptive proton therapy system that can be installed in a linac vault, announced today a collaboration with Hadassah Medical...(PRWeb June 28, 2022)Read the full story at https://www.prweb.com/releases/2022/6/prweb18759722.htm